Clinical trial Recruiting at 1 site Interventional Ages 40 to 75 Women only

Pectopexy vs Sacrocolpopexy for apical prolapse: learning curve and effectiveness

Official title: Comparison of the Effectiveness and Learning Curve of Laparoscopic Pectopexy Versus Laparoscopic Sacrocolpopexy in Treatment of Apical Prolapse

Run by Ain Shams University · NCT07596498 · Data updated 2026-11-12

This study tests whether laparoscopic pectopexy works as well as laparoscopic sacrocolpopexy for apical prolapse and how quickly surgeons become proficient.

Quick facts

Study typeInterventional
Ages40 Years to 75 Years
SexWomen only
Enrollment30 (estimated)
SponsorAin Shams University
Academic / other
Locations1 site (Cairo, Abbasia)
StatusRecruiting
StartedApril 1, 2026
Main results expectedOctober 1, 2026
Study endsOctober 10, 2026
Registry record updatedMay 19, 2026
Trial IDNCT07596498 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women with uterine or vault prolapse requiring surgery and POP-Q stage III or higher at Ain Shams University Hospital.

Probably not a fit

Patients with isolated anterior or posterior prolapse, pregnancy or lactation, or significant comorbidities may not benefit from these procedures.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective randomized trial compares two laparoscopic surgeries for apical pelvic organ prolapse: pectopexy using the iliopectineal ligament versus sacrocolpopexy at Ain Shams University Hospital. The study looks at surgical success and the learning curve for the two techniques, aiming to determine if pectopexy can provide comparable outcomes with potentially easier adoption. Participants have uterine or vault prolapse corresponding to POP-Q stage III or higher, and those with major contraindications or pregnancy-related conditions are excluded. Outcomes likely include anatomical correction, perioperative safety, and recovery factors, with follow-up to assess durability of repair. Prior evidence is largely retrospective; this trial adds prospective randomized data on effectiveness and surgeon learning curves.

Why it matters

Potential benefit: If successful, the trial could support broader use of pectopexy, potentially reducing operative difficulty and complication risk while preserving or improving prolapse correction.

How similar studies have gone: Previous studies suggesting high success for sacrocolpopexy are largely retrospective; this trial contributes randomized data on pectopexy.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients diagnosed with uterine prolapse with POP-Q stage ≥ III.
* Patients diagnosed with vault vaginal prolapse with POP-Q stage ≥ III.

Exclusion Criteria:

* Patients who refuse to participate in the study.
* Patients who have isolated anterior or posterior vaginal wall prolapse.
* Women who are pregnant or lactating.
* Patients with severe comorbidities, including: Serious heart, liver, kidney, or blood diseases or any condition preventing them from tolerating surgery.
* Women with a desire to conceive.

Where it's running

  • Ain Shams University Hospital
    Cairo, Abbasia, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.